Private Hospitals Carrying Out Illegal Gender Selection
By Saudi Gazette,
Saudi Gazette
| 12. 18. 2014
DAMMAM — Private hospitals are carrying out pre-conception gender selection operations and reporting them as IV fertilization or artificial fertilization in response to a growing number of patients’ requests, Al-Hayat daily reported.
Pre-conception gender selection operations are prohibited by the Ministry of Health although there are no religious prohibitions.
Sheikh Khalid Abdulah Al-Muslih said in his study on such procedures that scholars are split on the issue.
There is no religious text forbidding gender selection before conception, said Sheikh Al-Muslih.
Eastern Province Health Affairs spokesman Khalid Al-Osaimi said such operations are forbidden and would never happen in public hospitals. Sociologists believed parents who want such operations are looking to have boys, especially if there are none in their families.
Sociologist Saleh Al-Nimer said pre-conception gender selection operations have led to decreased rates of divorce in the Kingdom’s patriarchal society.
Many wives fear their husbands will replace them if they do not conceive a boy, said Al-Nimer.
The Eastern Province’s supervisor of private hospitals’ fertility units Dr. Essam Al-Hameed said these operations are not carried out in public hospitals, only private...
Related Articles
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...